Rotem Sorek

BiomX Ltd. engages in the development of customized phage therapies designed to target and destroy harmful bacteria in chronic diseases such as inflammatory bowel disease and colorectalcancer, as well as bacteria that affect the appearance of the skin. The company was founded by Eran Elinav, Timothy K. Lu, and Rotem Sorek on March 3, 2015 and is headquartered in Ness Ziona, Israel.

BiomX Ltd. engages in the development of customized phage therapies designed to target and destroy harmful bacteria in chronic diseases such as inflammatory bowel disease and colorectalcancer, as well as bacteria that affect the appearance of the skin. The company was founded by Eran Elinav, Timothy K. Lu, and Rotem Sorek on March 3, 2015 and is headquartered in Ness Ziona, Israel.

BiomX Ltd. engages in the development of customized phage therapies designed to target and destroy harmful bacteria in chronic diseases such as inflammatory bowel disease and colorectalcancer, as well as bacteria that affect the appearance of the skin. The company was founded by Eran Elinav, Timothy K. Lu, and Rotem Sorek on March 3, 2015 and is headquartered in Ness Ziona, Israel.

BiomX Ltd. engages in the development of customized phage therapies designed to target and destroy harmful bacteria in chronic diseases such as inflammatory bowel disease and colorectalcancer, as well as bacteria that affect the appearance of the skin. The company was founded by Eran Elinav, Timothy K. Lu, and Rotem Sorek on March 3, 2015 and is headquartered in Ness Ziona, Israel.

Part of Inventive Healthcare Solutions LLC, Virusight Diagnostic is a digital healthcare platform for immediate diagnosis of different pathogens, including COVID-19. The company is based in Ramat Gan, Israel. Virusight's technology is empowered by AI, providing pathogens diagnosis at the speed of light. Virusight is a joint venture between Newsight Imaging and ARC Innovation Center of Sheba Hospital, one of the top hospitals in the world. The Israeli company was founded in 2020, and the CEO is Rotem Sorek. Virusight Diagnostic was acquired by Inventive Healthcare Solutions LLC on August 16, 2021 for $34.52 million.

Part of Inventive Healthcare Solutions LLC, Virusight Diagnostic is a digital healthcare platform for immediate diagnosis of different pathogens, including COVID-19. The company is based in Ramat Gan, Israel. Virusight's technology is empowered by AI, providing pathogens diagnosis at the speed of light. Virusight is a joint venture between Newsight Imaging and ARC Innovation Center of Sheba Hospital, one of the top hospitals in the world. The Israeli company was founded in 2020, and the CEO is Rotem Sorek. Virusight Diagnostic was acquired by Inventive Healthcare Solutions LLC on August 16, 2021 for $34.52 million.

Part of Inventive Healthcare Solutions LLC, Virusight Diagnostic is a digital healthcare platform for immediate diagnosis of different pathogens, including COVID-19. The company is based in Ramat Gan, Israel. Virusight's technology is empowered by AI, providing pathogens diagnosis at the speed of light. Virusight is a joint venture between Newsight Imaging and ARC Innovation Center of Sheba Hospital, one of the top hospitals in the world. The Israeli company was founded in 2020, and the CEO is Rotem Sorek. Virusight Diagnostic was acquired by Inventive Healthcare Solutions LLC on August 16, 2021 for $34.52 million.

Part of Inventive Healthcare Solutions LLC, Virusight Diagnostic is a digital healthcare platform for immediate diagnosis of different pathogens, including COVID-19. The company is based in Ramat Gan, Israel. Virusight's technology is empowered by AI, providing pathogens diagnosis at the speed of light. Virusight is a joint venture between Newsight Imaging and ARC Innovation Center of Sheba Hospital, one of the top hospitals in the world. The Israeli company was founded in 2020, and the CEO is Rotem Sorek. Virusight Diagnostic was acquired by Inventive Healthcare Solutions LLC on August 16, 2021 for $34.52 million.